Recent studies have suggested that activated wild-type and mutant Janus kinase JAK2 play a role in the epigenetics of histone modification, where it phosphorylates histone H3 on tyrosine 41(H3pY41). We showed that type I IFN signaling involves activated TYK2 in the nucleus. ChIP-PCR demonstrated the presence of receptor subunits IFNAR1 and IFNAR2 along with TYK2, STAT1, and H3pY41 specifically at the promoter of the OAS1 gene in IFN treated cells. A complex of IFNAR1, TYK2, and STAT1α was also shown in the nucleus by immunoprecipitation. IFN treatment was required for TYK2 activation in the nucleus. The presence of IFNAR1, IFNAR2, and activated STAT1 and STAT2, as well as the type I IFN in the nucleus of treated cells was confirmed by the combination of Western blotting and confocal microscopy. Trimethylated histone H3 lysine 9 underwent demethylation and subsequent acetylation specifically in the region of the OAS1 promoter. Resultant N-terminal truncated IFN mimetics functioned intracellularly as antivirals as well as therapeutics against experimental allergic encephalomyelitis without the undesirable side effects that limit the therapeutic efficacy of IFNβ in treatment of multiple sclerosis. The findings indicate that IFN signaling is complex like that of steroid signaling.
Introduction
The classical model of cytokine signaling dominates our view of specific gene activation by cytokines such as the interferons (IFNs) (Levy and Darnell, 2002) . In this model, ligand activates the cell solely via interaction with the extracellular domain of the receptor complex. This in turn results in the activation of receptor or receptor-associated tyrosine kinases, primarily of the Janus or JAK kinase family, leading to phosphorylation and dimerization of the STAT transcription factors, which then disassociate from the receptor cytoplasmic domain and translocate to the nucleus. This view ascribes no further role to the ligand, JAKs, or the receptor in the signaling process. Further, there is the suggestion that the STAT transcription factors possess intrinsic nuclear localization sequences (NLSs) that are responsible for nuclear translocation of STATs and specific gene activation (reviewed in Johnson et al., 2004) .
It has recently been acknowledged that the classical model of JAK/STAT signaling was over-simplified in its original form, and that other ubiquitous pathways, including MAP kinase, PI3 kinase, CaM kinase II, and NF-κB cooperate with or act in parallel to JAK/STAT signaling to regulate IFNγ effects on the cell (Gough et al., 2008) . At the STAT level, there is evidence of a functional interaction between different STATs in gene activation/suppression, which provides more insight into STAT mediation of cytokine signaling (Yang et al., 2011) . It is not clear, however, as to how these STAT interactions at the level of DNA binding translate into specific gene activation by the inducing cytokine.
There is evidence that JAK kinases, including the wild type and mutant JAK2V617F, play an important role in the epigenetics of gene activation in addition to STAT activation in the cytoplasm, where tyrosine 41 on histone H3 is phosphorylated (H3pY41) (Dawson et al., 2009 ). We have shown in the case of IFNγ that receptor subunit IFNGR1 is associated with activated JAK2, pJAK2, which phosphorylated histone H3Y41 at the promoter of the IRF1 gene, while the β-actin gene was unaffected, since it is not acted on by IFNγ (Noon-Song et al., 2011) . In this report, we focus on activated TYK2, pTYK2, in the nucleus and at promoters of genes activated by type I IFNs. TYK2 is also activated by other cytokines such as IL-12 and IL-23, which have biological effects different from IFN (Duvallet et al., 2011; Jones and Vignali, 2011) . We were therefore particularly interested in whether there was an association between pTYK2 and type I IFN receptors at the promoters and chromatin of genes activated by these IFNs and whether such association provided insight into pTYK2 induced specific epigenetic events in genes activated by the IFNs. The findings provide insight into the mechanism of specific gene activation by type I IFNs, including the epigenetic events associated with JAK activation.
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